skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Novel approaches for the surgical treatment of atrial fibrillation: Time for a guideline revision?

Review

(2100) Views  (728) Full article downloads

Authors: Carlo Nicola De Cecco, Vitaliano Buffa, Vincenzo David, et al

Published Date June 2010 Volume 2010:6 Pages 439 - 447
DOI: http://dx.doi.org/10.2147/VHRM.S6962

Carlo Nicola De Cecco1,2, Vitaliano Buffa1, Vincenzo David2, Stefano Fedeli1

1Department of Cardiovascular Radiology, San Camillo-Forlanini Hospital, 2Department of Radiological Sciences, University of Rome, St Andrea Hospital, Rome, Italy

Abstract: Atrial fibrillation is a major health problem in Western countries, and is associated with considerable morbidity and resource consumption. Safe and reliable surgical techniques for the termination of this arrhythmia have been developed since the time of the original Cox “maze I” procedure. Novel equipment based on radiofrequency and microwave technologies can be employed to create transmural atrial lesions, even in the context of minimally invasive surgery to the atrioventricular valves via right minithoracotomy. The aim of this paper is to review the recent literature on this approach, and the clinical results in terms of arrhythmia termination and postoperative morbidity. With the aim to substantiate the practice of a simple, yet reliable, surgical ablation during minimally invasive heart valve surgery, we discuss the results of different patterns of atrial lesions having different degrees of surgical complexity. Finally, minimally invasive epicardial ablation for lone atrial fibrillation represents an emerging surgical indication. The results of state-of-the-art transcatheter ablation represent now its benchmark of comparison.

Keywords: atrial fibrillation, surgery, minimally invasive, outcomes








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia
Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection
Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
Practical recommendations for treatment of hypertension in older patients
Cardiac risk stratification: Role of the coronary calcium score
Recent advances in the management of chronic stable angina I: Approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities
Management of acute attacks of hereditary angioedema: potential role of icatibant
Effect of vascular burden as measured by vascular indexes upon vascular dementia: a matched case-control study
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University